Evidence-Based Medicine Guidelines
Immunosuppressive agents for myasthenia gravis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive Agents for Myasthenia Gravis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450604/all/Immunosuppressive_agents_for_myasthenia_gravis.
Immunosuppressive agents for myasthenia gravis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/450604/all/Immunosuppressive_agents_for_myasthenia_gravis. Accessed November 26, 2024.
Immunosuppressive agents for myasthenia gravis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450604/all/Immunosuppressive_agents_for_myasthenia_gravis
Immunosuppressive Agents for Myasthenia Gravis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450604/all/Immunosuppressive_agents_for_myasthenia_gravis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive agents for myasthenia gravis
ID - 450604
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450604/all/Immunosuppressive_agents_for_myasthenia_gravis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
